Clinical Trial Update: Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated the NSAID sulindac for preventing lung cancer in current or former smokers with bronchial dysplasia; the study has completed and resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchial Dysplasia
• Non-small Cell Lung Cancer

Drugs mentioned

• Sulindac (sulindac)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Precancerous Condition, Stage I Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-01-08